Clinical trials: Immunisation
Tonsillitis, Hypertrophy
Immune Response To Intranasal Influenza Vaccination
This research during the last decade has focused on the kinetics of the systemic and local immune response to parenteral influenza vaccine in humans.
- Trial name
- NCT01866540
- Testing
- FLUENZ
- Where
- Norway
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- University of Bergen
Pneumococcal Infections
Mother's Gift Project
This prospective randomized evaluation of pneumococcal vaccine immunization of pregnant mothers, followed by pneumococcal conjugate immunization of their children is designed to assess the effects of these strategies on the…
- Trial name
- NCT00142389
- Testing
- pneumococcal polysaccharide and protein conjugate vaccines
- Where
- Bangladesh
- Volunteers
- 680 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
CKD (Chronic Kidney Disease) Stage 5D, Pneumonia
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients
The investigators compare two strata of vaccinated patients: those recently vaccinated and those vaccinated more than two years ago. The primary objective is to compare pneumonia rates between the groups.
- Trial name
- DOPPIO (NCT03350425)
- Where
- 12 sites in Germany
- Volunteers
- 792 people
- Sponsor
- University of Cologne
Coronavirus
COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents
This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles.
- Trial name
- NCT04542395
- Testing
- Increasing Willingness and Uptake of COVID-19 Testing and Vaccination
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Charles Drew University of Medicine and Science
Seasonal Influenza
The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates
The investigators conducted a 3-arm randomized controlled trial to test whether a low-cost planning intervention could increase influence vaccination rates.
- Trial name
- NCT01207232
- Testing
- Planning Prompt, Control Condition
- Where
- United States
- Volunteers
- 3,272 people
- Sponsor
- University of Pennsylvania
Multiple Myeloma, Plasmocytoma
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
Patients with stage-I multiple myeloma are treated with a vaccine made from their own immune cells (dendritic cells) and their own myeloma protein. Vaccinations are given on 5 occasions every 4 weeks.
- Trial name
- NCT00988312
- Testing
- autologous idiotype-protein pulsed dendritic cells
- Where
- Germany
- Volunteers
- 9 people
- Sponsor
- University Hospital Carl Gustav Carus
HIV
A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR
This trial will investigate whether immunizations with an MVA recombinant HIV vaccine are safe and whether they will boost immune responses generated by immunizations with a dendritic cell (DC) targeted protein vaccine…
- Trial name
- NCT01889719
- Testing
- MVA-CMDR
- Where
- United States
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- Rockefeller University
Rabies
Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.
- Trial name
- RABVAX (NCT02374814)
- Testing
- Rabies vaccine
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- State University of New York - Upstate Medical University
Vaccination Refusal
Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)
Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake. These include household vaccination visits instead of community vaccination clinic.monetary and non-monetary…
- Trial name
- NCT05225064
- Testing
- Incentives to be vaccinated, Mask, Encouragement to wear a mask
- Where
- India
- Volunteers
- 114,512 people, healthy volunteers welcome
- Sponsor
- Yale University
Hepatitis B
Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination
An observational study will be performed in subjects aged 3-65 years old to describe the dynamic changes of cellular immunity after vaccination of hepatitis B vaccine, and to find out the expression levels of Th9 cells and IL9 in…
- Trial name
- NCT01441609
- Where
- China
- Volunteers
- 94 people, healthy volunteers welcome
- Sponsor
- Beijing Municipal Science & Technology Commission
Cervical Cancer, Human Papillomavirus Infection
Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women
This study evaluated the effect of a Health Belief Model-based educational intervention on women's knowledge of cervical cancer and their attitudes and beliefs toward HPV vaccination.
- Conditions
- Cervical Cancer, Human Papillomavirus Infection, Preventive Health Services
- Trial name
- HBM-HPV (NCT07521163)
- Testing
- Health Belief Model-Based Education
- Where
- Turkey (Türkiye)
- Volunteers
- 154 people, healthy volunteers welcome
- Sponsor
- Muhammet Faruk Yigit
Vaccinia
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital.
- Trial name
- StatutvaxPat (NCT06616753)
- Testing
- vaccination status
- Where
- France
- Volunteers
- 140 people
- Sponsor
- Groupe Hospitalier Sud Ile-de-France
Influenza Virus Vaccine Adverse Reaction, Influenza Vaccine Allergy
Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
Seasonal influenza vaccination was used to assess whether induction of immunity as well as the rate of side effects is influenced by the timing of the last training session before vaccination.
- Trial name
- NCT03654937
- Testing
- Influenza Vaccination
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Universität des Saarlandes
Pneumonia
Pneumococcal Adult-dose Ranging Immunization Study
The purpose of this study is to give seniors different doses of a new pneumococcal vaccine called PCV7 to evaluate the safety of the vaccine and compare the immune response to find out which amount gives the best immune response.
- Trial name
- NCT00169234
- Testing
- PCV7, Prevnar®, Pneumovax 23
- Where
- 2 sites in United States
- Volunteers
- 220 people
- Sponsor
- Kaiser Permanente
HPV Vaccine, HPV
Adaptation Of An HPV Education Resource To Promote HPV Vaccination
The purpose of the study is to assess Human Papillomavirus (HPV) and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences for learning more about HPV and HPV…
- Trial name
- NCT04974619
- Testing
- Online survey, Focus groups or Individual Interviews, Interviews
- Where
- 2 sites in United States, Puerto Rico
- Volunteers
- 155 people, healthy volunteers welcome
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
Type I Hypersensitivity
Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
Allergen-specific immunotherapy (SIT), the administration of gradually increasing quantities of an allergen extract to an allergic patient, is a curative approach which directly treats the underlying allergic disease.
- Trial name
- NCT00118612
- Testing
- Tree MATA MPL - Therapeutic Regimen, Tree MATA MPL - Intermediate dose, Tree MATA MPL - Low dose
- Where
- Canada
- Volunteers
- 68 people
- Sponsor
- Allergy Therapeutics
Bladder Cancer
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer
The purpose of this study is to evaluate the safety and clinical efficacy of novel vaccination for advanced bladder cancer.
- Trial name
- NCT00635336
- Testing
- MPHOSPH1 and DEPDC1
- Where
- Japan
- Volunteers
- 20 people
- Sponsor
- Iwate Medical University
HPV16 Anitbody Levels Post Vaccination, HPV18 Antibody Levels Post Vaccination
HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda
Background: Cervical cancer is one of the leading causes of cancer death in women worldwide and in Uganda. It is caused by the human papillomavirus (HPV).
- Trial name
- NCT01520272
- Where
- Uganda
- Volunteers
- 376 people, healthy volunteers welcome
- Sponsor
- National Cancer Institute (NCI)
Vaccine Hesitancy, Vaccine Refusal
Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents
Vaccines currently prevent several million deaths every year and more lives could be saved if vaccination take up increased. The World Health Organization identifies vaccine hesitancy as one of the ten most important threats to…
- Conditions
- Vaccine Hesitancy, Vaccine Refusal, Health Knowledge, Attitudes, Practice
- Trial name
- Kidivax (NCT06155877)
- Testing
- Activité Vaccins et Vaccination - LAMAP, Kidivax Chatbot
- Where
- France
- Volunteers
- 8,590 people, healthy volunteers welcome
- Sponsor
- Centre National de la Recherche Scientifique, France
Vaccine Refusal
Understanding and Overcoming the Racial/Ethnic Inequalities in COVID-19 Vaccination Acceptance
With the constant threat of new epidemic waves and the emergence of variants, COVID-19 resilience can only be attained when a sufficient level of immunity is achieved.
- Trial name
- NCT05238428
- Testing
- Trust boost
- Where
- United Kingdom
- Volunteers
- 4,039 people, healthy volunteers welcome
- Sponsor
- University of Essex